Holen Sie sich die Stockscreener-App
4.25
2.30%
-0.09
Schlusskurs vom Vortag:
$4.34
Offen:
$4.38
24-Stunden-Volumen:
290.45K
Relative Volume:
0.93
Marktkapitalisierung:
$89.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-94.11M
KGV:
-0.7072
EPS:
-6.01
Netto-Cashflow:
$-86.06M
1W Leistung:
+43.73%
1M Leistung:
+40.17%
6M Leistung:
-14.00%
1J Leistung:
-35.66%
1-Tages-Spanne:
$4.01
$4.42
1-Wochen-Bereich:
$2.95
$5.19
52-Wochen-Spanne:
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Firmenname
Adverum Biotechnologies Inc
Sektor
Branche
Telefon
(650) 649-1004
Adresse
100 CARDINAL WAY, REDWOOD CITY, CA
Vergleichen Sie ADVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
4.25 | 91.07M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
380.44 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.74 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.94 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
708.69 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.56 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-07 | Hochstufung | Truist | Hold → Buy |
| 2021-07-23 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | Herabstufung | Truist | Buy → Hold |
| 2020-12-16 | Eingeleitet | UBS | Neutral |
| 2020-11-12 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-05-05 | Hochstufung | SunTrust | Hold → Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-16 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-10 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Neutral |
| 2019-09-13 | Bestätigt | Chardan Capital Markets | Neutral |
| 2019-06-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-11-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-08-30 | Eingeleitet | SunTrust | Buy |
| 2018-02-15 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Adverum Biotechnologies Inc Aktie (ADVM) Neueste Nachrichten
Analyzing Adverum Biotechnologies Inc. with multi timeframe chartsEarnings Recap Report & Long-Term Safe Investment Plans - newser.com
Mizuho reiterates Outperform rating on Adverum stock amid positive trial updates - Investing.com Canada
Adverum Biotechnologies’ (ADVM) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Short interest data insights for Adverum Biotechnologies Inc.2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
HC Wainwright Reiterates Buy Rating for Adverum Biotechnologies (NASDAQ:ADVM) - MarketBeat
Adverum accelerates enrollment timeline for wet AMD gene therapy trial By Investing.com - Investing.com Nigeria
How to forecast Adverum Biotechnologies Inc. trends using time seriesEarnings Risk Summary & Growth Focused Stock Reports - newser.com
Adverum Biotechnologies (NASDAQ:ADVM) Stock Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Will Adverum Biotechnologies Inc. stock go up soonInsider Buying & Free Verified High Yield Trade Plans - newser.com
Should you wait for a breakout in Adverum Biotechnologies Inc.2025 Market Trends & Safe Swing Trade Setups - newser.com
Using Ichimoku Cloud for Adverum Biotechnologies Inc. technicalsStock Surge & Long-Term Safe Investment Plans - newser.com
Trend analysis for Adverum Biotechnologies Inc. this weekWeekly Stock Recap & Safe Investment Capital Preservation Plans - newser.com
Adverum Biotechnologies Announces Completion of Screening - GlobeNewswire
Adverum Biotechnologies Announces Completion of Screening for Pi - GuruFocus
Major Timeline Acceleration: Adverum's One-And-Done Eye Treatment Trial Hits Key Milestone 3 Months Early - Stock Titan
What technical models suggest about Adverum Biotechnologies Inc.’s comebackProduct Launch & AI Powered Market Entry Ideas - newser.com
Developing predictive dashboards with Adverum Biotechnologies Inc. dataJuly 2025 Gainers & Technical Pattern Based Buy Signals - newser.com
Analysis Recap: Will Adverum Biotechnologies Inc be affected by tariffs2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - خودرو بانک
Adverum Biotechnologies, Inc.(NasdaqCM: ADVM) dropped from S&P Global BMI Index - MarketScreener
Trexquant Slashes Stake in Adverum Biotechnologies, Inc. (ADVM) - MSN
Is Adverum Biotechnologies Inc. meeting your algorithmic filter criteriaOil Prices & Capital Protection Trade Alerts - newser.com
What momentum shifts mean for Adverum Biotechnologies Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - newser.com
Advanced analytics toolkit walkthrough for Adverum Biotechnologies Inc.July 2025 Recap & Precise Swing Trade Alerts - newser.com
Market Fear: Is Adverum Biotechnologies Inc forming a breakout pattern2025 Pullback Review & Fast Entry Momentum Alerts - khodrobank.com
Applying chart zones and confluence areas to Adverum Biotechnologies Inc.2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
What’s next for Adverum Biotechnologies Inc. stock priceGap Down & Expert Approved Trade Ideas - newser.com
Using data filters to optimize entry into Adverum Biotechnologies Inc.Weekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
Value Recap: Will Adverum Biotechnologies Inc benefit from rate cutsJuly 2025 Retail & Daily Profit Maximizing Tips - خودرو بانک
Is Adverum Biotechnologies Inc. likely to announce a buyback2025 Biggest Moves & Community Shared Stock Ideas - khodrobank.com
Evaluating Adverum Biotechnologies Inc. with trendline analysisTrade Analysis Summary & Scalable Portfolio Growth Ideas - newser.com
Is Adverum Biotechnologies Inc. reversing from oversold territoryMarket Activity Recap & Verified Swing Trading Watchlists - newser.com
Using R and stats models for Adverum Biotechnologies Inc. forecasting2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
Macro Review: What is the earnings history of Adverum Biotechnologies IncAnalyst Downgrade & Weekly Market Pulse Alerts - خودرو بانک
Earnings Beat: Is Adverum Biotechnologies Inc showing insider buyingCPI Data & AI Enhanced Trading Signals - خودرو بانک
Big Picture: What drives Adverum Biotechnologies Incs stock priceTrade Volume Summary & AI Forecast for Swing Trade Picks - خودرو بانک
Investor Mood: Should I hold or sell Adverum Biotechnologies Inc nowAnalyst Downgrade & Safe Capital Growth Trade Ideas - khodrobank.com
Market Recap: What is the long term forecast for Adverum Biotechnologies Inc stock2025 Winners & Losers & Fast Moving Trade Plans - khodrobank.com
Geopolitics Watch: How does Adverum Biotechnologies Inc compare to its peersQuarterly Risk Review & Growth Focused Investment Plans - خودرو بانک
Trexquant Investment LP Sells 77,303 Shares of Adverum Biotechnologies, Inc. $ADVM - MarketBeat
Investment Recap: Is Adverum Biotechnologies Inc showing insider buying2025 Technical Patterns & Accurate Buy Signal Alerts - خودرو بانک
Finanzdaten der Adverum Biotechnologies Inc-Aktie (ADVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adverum Biotechnologies Inc-Aktie (ADVM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER |
May 15 '25 |
Sale |
2.00 |
924 |
1,848 |
13,768 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
May 15 '25 |
Sale |
2.00 |
9,126 |
18,252 |
87,488 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 27 '25 |
Buy |
5.19 |
16,593 |
86,089 |
141,800 |
| Leonard Braden Michael | 10% Owner |
Apr 22 '25 |
Buy |
3.00 |
300,000 |
900,000 |
3,057,526 |
| Leonard Braden Michael | 10% Owner |
Apr 23 '25 |
Buy |
2.98 |
50,000 |
148,950 |
191,800 |
| Leonard Braden Michael | 10% Owner |
Mar 31 '25 |
Buy |
4.38 |
19,566 |
85,668 |
2,742,317 |
| Leonard Braden Michael | 10% Owner |
Apr 02 '25 |
Buy |
4.04 |
15,209 |
61,408 |
2,757,526 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 18 '25 |
Buy |
4.69 |
62,341 |
292,418 |
2,667,161 |
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):